Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a c
- This topic has 0 replies, 1 voice, and was last updated 5 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/30736852
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.